AstraZeneca PLC, steering clear of the recent wave of large-scale acquisitions in the pharmaceutical industry, is sizing up potential purchases of smaller European drug makers.
Chief Executive David Brennan said in an interview that the U.K. drug maker will take a look at "some smaller companies that appear to be coming up for sale in Europe."
Entradas
No hay comentarios:
Publicar un comentario